Blocking histamine receptor H1 on macrophages with anti-allergy drugs restores T-cell anti-tumor immunity.

被引:0
|
作者
Li, Hongzhong [1 ]
Xiao, Yi [1 ]
Yao, Jun [1 ]
Yuan, Xiangliang [1 ]
Yin, Xuedong [1 ]
Zhang, Yuan [1 ]
Saito, Yohei [1 ]
Yagita, Hideo [2 ]
Gibbons, Don [1 ]
Yu, Dihua [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Juntendo Univ, Sch Med, Tokyo, Japan
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
2794
引用
收藏
页数:1
相关论文
共 50 条
  • [41] Allorestricted T lymphocytes with a high avidity T-cell receptor towards NY-ESO-1 have potent anti-tumor activity
    Kroenig, Holger
    Hofer, Kathrin
    Conrad, Heinke
    Guilaume, Philippe
    Mueller, Julia
    Schiemann, Matthias
    Lennerz, Volker
    Cosma, Antonio
    Peschel, Christian
    Busch, Dirk H.
    Romero, Pedro
    Bernhard, Helga
    INTERNATIONAL JOURNAL OF CANCER, 2009, 125 (03) : 649 - 655
  • [42] Pparα Ablation Suppresses T Cell Responses and Anti-Tumor Immunity By Compromising the Antigen-Presenting Properties of Tumor-Associated Macrophages
    Christofides, Anthos
    Cao, Carol
    Wang, Qi
    Tijaro-Ovalle, Natalia M.
    Konstantinidou, Eirini
    Shah, Rushil
    Jani, Chinmay
    Pal, Rinku
    Aksoylar, Halil-Ibrahim
    Patsoukis, Nikolaos
    Boussiotis, Vassiliki A.
    BLOOD, 2021, 138
  • [43] PD-1 BLOCKADE ADMINISTERED BEFORE OR AT THE TIME OF T CELL ACTIVATION ENHANCES ANTI-TUMOR IMMUNITY
    Moseman, Jena
    McNeel, Douglas
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A492 - A492
  • [44] Dgat1 camouflages sexual dimorphism in anti-tumor CD8+T cell immunity
    Madi, Alaa
    Cui, Guoliang
    CANCER IMMUNOLOGY RESEARCH, 2023, 11 (12)
  • [45] Induced expression of B7-H3 on the lung cancer cells and macrophages suppresses T-cell mediating anti-tumor immune response
    Chen, Cheng
    Shen, Yu
    Qu, Qiu-Xia
    Chen, Xu-Qin
    Zhang, Xue-Guang
    Huang, Jian-An
    EXPERIMENTAL CELL RESEARCH, 2013, 319 (01) : 96 - 102
  • [46] Targeting the Stroma to Enhance T-Cell Infiltration and Anti-tumor Response to Anti-PD1 Antibody in Pancreatic Ductal Adenocarcinoma
    Osipov, A.
    Zheng, L.
    PANCREAS, 2020, 49 (10) : 1422 - 1423
  • [47] The Potential of T Cell Factor 1 in Sustaining CD8+T Lymphocyte-Directed Anti-Tumor Immunity
    Jung, Sungmin
    Baek, Jea-Hyun
    CANCERS, 2021, 13 (03) : 1 - 17
  • [48] New Strategy of Adult T-cell Leukemia Treatment Targeted for Anti-tumor Immunity and a Longevity Gene-encoded Protein
    Kozako, Tomohiro
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2011, 131 (07): : 1061 - 1072
  • [49] Chimeric antigen receptor macrophages (CAR-M) induce anti-tumor immunity and synergize with T cell checkpoint inhibitors in pre-clinical solid tumor models.
    Pierini, Stefano
    Gabbasov, Rashid
    Gabitova, Linara
    Ohtani, Yumi
    Shestova, Olga
    Gill, Saar
    Abramson, Sascha
    Condamine, Thomas
    Klichinsky, Michael
    CANCER RESEARCH, 2021, 81 (13)
  • [50] A TIGIT-based chimeric co-stimulatory switch receptor improves T-cell anti-tumor function
    Hoogi, Shiran
    Eisenberg, Vasyl
    Mayer, Shimrit
    Shamul, Astar
    Barliya, Tilda
    Cohen, Cyrille J.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7 (01): : 243